Benzinga’s Volume Movers (AMLN, ALKS, FNSR, PEGA, BIDU)

Amylin Pharmaceuticals, Inc (NASDAQ: AMLN) shares gained 16.14% to $23.53. The volume of AMLN shares traded was 521% higher than normal. AMLN’s shares popped after the FDA responded positively to a new drug application (NDA) for diabetes filed by the company and its development partners.

Alkermes, Inc (NASDAQ: ALKS) shares climbed 15.40% to $14.09. The volume of ALKS shares traded was 395% higher than normal. ALKS shares jumped after the FDA responded positively to a new drug application for diabetes filed by the company and its development partners AMLN and Eli Lilly and Co (NYSE: ELY)

Finisar Corporation (NASDAQ: FNSR) shares jumped 5.51% to $14.75. The volume of FNSR shares traded was 159% higher than normal. Auriga USA initiated coverage of FNSR with a “buy” rating.

Pegasystems Inc (NASDAQ: PEGA) shares rose 6.00% to $39.04. The volume of PEGA shares traded was 154% higher than normal. PEGA is acquiring Chordiant Software (NASDAQ: CHRD) for $162 million.

Baidu Inc (NASDAQ: BIDU) shares moved up 5.30% to $579.42. The volume of BIDU shares traded was 148% higher than normal. BIDU jumped today following reports that rival Google Inc (NASDAQ: GOOG) is close to taking a decision on closing its search engine in China.

Read more from Benzinga's Markets.